Bipolar Transurethral Plasmakinefic Prostatectomy for 87 Cases of Benign Prostatic Hyperplasia

Objective To evaluate the curative effect of bipolar transurethral plasmakinetic prostateetomy(TUPKP)in the treatment of benign prostate hyperplasia(BPH).Method We summarized the clinical data of 89 patients with BPH treated with TUPKP.Results The resected tissues weighed 21～103 g,52 g on average.The operation lasted 25～100 min,55 min on average.No transurethral resection syndrome(TURS) occurred.The patients were followed up for 3～9 months,the maximum flow rate(MFR)increased from(7.5±3.8)mL/s to(23.2±5.1)mL/s;the average flow rate(AFR)increased from(5.3±0.4)mL/s to(11.8±1.9)mL/s;the international prostate symptom score(IPSS)decreased from(27.3±3.4)to(6.2±1.9);the residual urine(RU)decreased from(127.6± 34.3)mL to(16.9±6.5)mL;the quality of life(QOL)scores decreased from(5.3±0.8)to(1.9±0.3),the difference was statistically significant between before and after surgery(P0.05).Conclusion TUPKP is a minimally invasive,safe,reliable,and effective treatment with few complications for BPH.